المؤلفون: Ibfelt EH, Sørensen J, Jensen DV, Dreyer L, Schiøttz-Christensen B, Thygesen PH, Colic A, Raun JL, Manilo N, Rødgaard A, Poulsen UE, Rasmussen C, Hansen T, Unger B, Pelck R, Kincses A, Nordin H, Lorenzen T, Theibich A, Jensen Hansen IM, Espesen J, Grydehøj J, Holland-Fischer M, Loft AG, Hetland ML

المصدر: Clinical Epidemiology, Vol Volume 9, Pp 627-632 (2017)

مصطلحات موضوعية: Rheumatoid Arthritis, Validity, Incidence, Clinical Registry, Denmark, Infectious and parasitic diseases, RC109-216

وصف الملف: electronic resource

Relation: https://www.dovepress.com/validity-and-completeness-of-rheumatoid-arthritis-diagnoses-in-the-nat-peer-reviewed-article-CLEP; https://doaj.org/toc/1179-1349

URL الوصول: https://doaj.org/article/cfd67ae845a24025b8748f2637e7685c

المؤلفون: Nabi, H., Glintborg, B., Loft, A. G., Hendricks, O., Pedersen, J. K., Just, S. A., Ahmed, R., Danebod, K., Munk, H. L., Colic, A., Linauskas, A., Jensen, D. V., Christensen, L. B., Manilo, N., Lomborg, N., Kristensen, S., Mehnert, F., Krogh, N. S., Hetland, M. L.

المصدر: Nabi, H, Glintborg, B, Loft, A G, Hendricks, O, Pedersen, J K, Just, S A, Ahmed, R, Danebod, K, Munk, H L, Colic, A, Linauskas, A, Jensen, D V, Christensen, L B, Manilo, N, Lomborg, N, Kristensen, S, Mehnert, F, Krogh, N S & Hetland, M L 2021, ' Multiple infliximab biosimilar switches : results following a nationwide switch from originator infliximab to biosimilar CT-P13, and subsequently to biosimilar GP1111, in real-world patients with inflammatory arthritis followed in the Danish DANBIO registry ', Scandinavian Journal of Rheumatology, vol. 50, no. Suppl. 130, OP16, pp. 14-15 . < https://doi.org/10.1080/03009742.2021.1951065 >

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od______3062::e86135f0598e45c081503a1d1888748b
https://portal.findresearcher.sdu.dk/da/publications/39a45740-1554-44e5-abed-7dbb3ad48065

المؤلفون: Glintborg, B., Sorensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Danebod, K., Jensen, D. V., Nordin, H., Hendricks, O., Loft, A. G., Chrysidis, S., Andersen, B. L., Raun, J. L., Lindegaard, H., Espesen, J., Jakobsen, S. H., Hansen, I. J., Dalgaard, E. B., Pedersen, D. D., Kristensen, S., Linauskas, A., Andersen, L. S., Grydehoj, J., Krogh, N. S., Merete Lund Hetland

المصدر: Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Dorte Vendelbo, J, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H, Espesen, J, Højmark Jakobsen, S, Jensen Hansen, I M, Dalsgaard, E B, Pedersen, D D, Kristensen, S, Linauskas, A, Andersen, L S, Grydehøj, J, Krogh, N S & Hetland, M L 2018, ' One year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. An observational DANBIO study ', EULAR 2018, Amsterdam, Netherlands, 13/06/2018-16/06/2018 . https://doi.org/10.1136/annrheumdis-2018-eular.2296
Publons
Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Jensen, D V, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H M, Espesen, J, Højmark Jakobsen, S, Jensen Hansen, I M, Dalsgaard, E B, Pedersen, D D, Kristensen, S, Linauskas, A, Andersen, L S, Grydehøj, J, Krogh, N S, Hetland, M L & The Danbio registry and the Danish Departments of Rheumatology, Copenhagen, Denmark 2018, ' One-year follow-up of a nationwide cohort of patients with inflammatory arthritis, who switched from originator to biosimilar etanercept, focusing on patients who switched back to originator. an observational danbio study ', Annals of the Rheumatic Diseases, vol. 77, no. Suppl. 2, FRI0103, pp. 595-596 . < https://ard.bmj.com/content/77/Suppl_2/595.2 >

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::88d69356f518442c91d4a515407229f4
https://portal.findresearcher.sdu.dk/da/publications/64c18d6e-6001-46f4-b808-4df22154f892

المؤلفون: Bente Glintborg, Sørensen, I. J., Omerovic, E., Mehnert, F., Manilo, N., Kamilla Danebod, Dorte Vendelbo Jensen, Henrik Nordin, Anne Gitte Loft, Oliver Hendricks, Chrysidis, S., Andersen, B. L., Johnny Lillelund Raun, Hanne Lindegaard, Jakob Espesen, Jakobsen, S. H., Inger Marie Jensen Hansen, Dalsgaard, E. B., Pedersen, D. D., Kristensen, S., Asta Linauskas, Andersen, L. S., Grydehøj, J., Krogh, N., Merete Lund Hetland

المصدر: Glintborg, B, Sørensen, I J, Omerovic, E, Mehnert, F, Manilo, N, Danebod, K, Jensen, D V, Nordin, H, Loft, A G, Hendricks, O, Chrysidis, S, Andersen, B L, Lillelund Raun, J, Lindegaard, H, Espesen, J, Jakobsen, S H, Jensen Hansen, I M, Dalsgaard, E B, Pedersen, D D, Kristensen, S, Linauskas, A, Andersen, L S, Grydehøj, J, Krogh, N & Hetland, M L 2018, ' One-year treatment retention after a nationwide non-medical switch from originator to biosimilar etanercept in 2,061 patients with inflammatory arthritis followed in the DANBIO registry ', Annals of the Rheumatic Diseases, vol. 77, no. Suppl. 2, THU0189, pp. 313-314 . < https://ard.bmj.com/content/77/Suppl_2/313 >
University of Southern Denmark

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::271ebee78be7a4214928dcb613efc55b
https://portal.findresearcher.sdu.dk/da/publications/c84ac887-c412-46b6-88dd-2708ae8f8844

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.